Key facts
- PVH Corp. lowered its full-year revenue outlook to flat, causing its shares to drop over 25%.
- Commvault Systems faces a securities class action lawsuit following a 31% stock decline.
- Oculis Holding AG shares fell over 23% after its Phase 3 trial for OCS-01 DME failed.
- Via Transportation is being investigated for potential securities fraud related to inaccurate statements.
- Stellantis N.V. investors are subject to a securities fraud lawsuit for purchases made between February 26, 2025, and February 5, 2026.
- Monteverde & Associates PC is investigating mergers involving CZNL, ESQ, GDOT, SEM, CZR, OMEX, SILA, and EVTV.
- POET Technologies Inc. is under investigation for securities fraud for purchases between April 1, 2026, and April 27, 2026.
- Investors with losses exceeding $100,000 in POET Technologies can lead the securities fraud lawsuit.
- A deadline of June 29, 2026, exists for POET Technologies investors to seek lead plaintiff status.
- Sana Biotechnology, Inc. and Five9, Inc. insiders are being investigated for potential breaches of fiduciary duty.
- Wolf Haldenstein Adler Freeman & Herz LLP is investigating Sleep Number Corporation for potential securities fraud.
A wave of investigations by various law firms targets numerous publicly traded companies for alleged securities fraud and breaches of fiduciary duty. PVH Corp. is under scrutiny after cutting its full-year revenue outlook to flat, leading to a stock drop of over 25%. The Schall Law Firm is investigating potential breaches of fiduciary duty by PVH's officers and directors.
Commvault Systems faces a securities class action lawsuit following a 31% stock decline, with allegations that the company failed to meet projected net new ARR growth due to an ARR mix shift. Robbins LLP is urging investors who bought Commvault securities between April 29, 2025, and January 26, 2026, to contact the firm, while investors have until July 17, 2026, to act.
Oculis Holding AG is being investigated by Levi & Korsinsky after its OCS-01 DME program's Phase 3 DIAMOND trials failed. The company's shares fell over 23% amid allegations that SEC filings had described the program as on track for FDA submission despite the trial failure.
Via Transportation is being investigated by Ademi LLP for potential securities fraud related to inaccurate statements about its financial statements and business operations. Similarly, Stellantis N.V. investors are reminded by Rosen Law Firm of a securities fraud lawsuit for purchases made between February 26, 2025, and February 5, 2026, with opportunities to lead the lawsuit.
Monteverde & Associates PC has launched legal inquiries into merger transactions involving CZNL, ESQ, GDOT, and SEM, as well as CZR, OMEX, SILA, and EVTV. The firm is investigating potential claims for shareholders harmed by these transactions, noting that insiders might receive benefits not available to ordinary shareholders. Monteverde & Associates PC is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.
Several companies are being investigated for securities fraud, with opportunities for investors to lead class action lawsuits. These include Phreesia Inc., POET Technologies Inc. (for purchases between April 1, 2026, and April 27, 2026, with losses over $100,000 and a deadline of June 29, 2026, to seek lead plaintiff status), Calix, Inc., SES AI Corporation, and Sportradar Group AG. The Law Offices of Frank R. Cruz is seeking lead plaintiffs for cases involving Phreesia, Calix, and SES AI Corp., while Glancy Prongay Wolke & Rotter LLP is seeking lead plaintiffs for Sportradar Group.
Furthermore, Sana Biotechnology, Inc. and Five9, Inc. are subjects of investigations into potential breaches of fiduciary duty by their insiders. Shareholders are invited to contact the investigating firms to discuss their rights and options, often on a contingent fee basis. Wolf Haldenstein Adler Freeman & Herz LLP is investigating Sleep Number Corporation for potential securities fraud claims.